Viewing Study NCT06533332


Ignite Creation Date: 2025-12-24 @ 9:56 PM
Ignite Modification Date: 2026-01-09 @ 12:58 PM
Study NCT ID: NCT06533332
Status: RECRUITING
Last Update Posted: 2025-09-18
First Post: 2024-07-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Sponsor: EtiraRx Australia Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module